home / stock / invvy / invvy news


INVVY News and Press, Indivior PLC ADR From 09/26/18

Stock Information

Company Name: Indivior PLC ADR
Stock Symbol: INVVY
Market: OTC
Website: indivior.com

Menu

INVVY INVVY Quote INVVY Short INVVY News INVVY Articles INVVY Message Board
Get INVVY Alerts

News, Short Squeeze, Breakout and More Instantly...

INVVY - Indivior Provides Update on Key Business Drivers and Expectations

SLOUGH, U.K. and RICHMOND, Va. , Sept. 26, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today is providing a further update on key business drivers and expectations related to: FY 2018 net revenue and net income guidance; SUBLOCADE™ net revenue development; ...

INVVY - Indivior Unable to Participate in Morgan Stanley Healthcare Conference Due to Adverse Weather

SLOUGH, England and RICHMOND, Va. , Sept. 12, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that due to adverse weather expected from Hurricane Florence, the recently declared state of emergency in Virginia and its likely impact on East Coast travel, the Company is ...

INVVY - Indivior Prepays $150 Million of Outstanding Debt

SLOUGH, England and RICHMOND, Va. , Sept. 10, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that it has completed the prepayment of $150 million of its outstanding Term loan facilities. As a result, outstanding borrowing under the Term loan facilities is $333 milli...

INVVY - Senate vote approaches on bill to combat opioid crisis

The Senate will vote next week on the Opioid Crisis Response Act, a lineup of over 70 proposals to fight the opioid crisis following the 50 opioid-related bills that passed the House in June. More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news...

INVVY - Aquestive Therapeutics Reports Second Quarter 2018 Financial Results and Recent Business Highlights, Including Tentative Approval for Sympazan(TM)

WARREN, N.J. , Sept. 4, 2018 /PRNewswire/ -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to address unmet medical needs, today reported financial results for the second quart...

INVVY - DURECT Announces Receipt of $5 Million Milestone Payment from Indivior

CUPERTINO, Calif. , Aug. 30, 2018 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it has received a $5 million milestone payment from Indivior PLC (LON: INDV), triggered by Indivior's approval of the New Drug Application (NDA) for PERSERIS ™ (risperidone) ...

INVVY - FDA updates on multifaceted plan to combat opioid crisis

In a statement , FDA Commissioner Scott Gottlieb, M.D. outlines the FDA's many initiatives aimed at addressing the U.S. opioid crisis. Key points: More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news, Read more ...

INVVY - FDA clamps down on opioid-peddling websites

The FDA has sent Warning Letters to four additional online networks operating a total of 21 websites for illegally promoting opioids to Americans. The action follows the issuance of 13 Warning Letters to more than 70 websites over the summer. More news on: Endo International plc, Mallinc...

INVVY - FDA awards contract to develop guidelines for opioid prescribing

The FDA has awarded a contract to the National Academies of Sciences, Engineering and Medicine to help advance the development of evidence-based guidelines to help physicians prescribe opioid pain meds in a more appropriate way. More news on: Endo International plc, Mallinckrodt PLC, IND...

INVVY - White House proposing cuts in opioid production

Aimed at fighting the U.S. opioid crisis, the Trump administration is proposing production cuts in the most-abused compounds, oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine and fentanyl, by 10% next year. More news on: Endo International plc, Mallinckrodt PLC, Johnson &...

Previous 10 Next 10